Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
ECB raises rates by unprecedented 75 basis points
-
Dollar rises on risk aversion; euro revisits parity
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Euro strengthens after ECB hikes faster than flagged
-
Dollar dips as rate hike bets ease
-
Euro falls below parity for the first time in 2 decades
-
Muted start to new quarter for European equities as recession worries weigh
-
Rally House Brings 7th Store to Cleveland Market
-
Dollar index jumps to two-decade high as traders await Fed rate move
-
Dollar recovers ground as risk appetite fades
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Instant View: Fed hikes 50 bp, Powell tamps down speculation of 75 bp hike
-
Stocks rally after Fed hikes rates, crude jumps
-
CarVal Investors Announces Growth of U.S. Commercial Real Estate Finance Business
-
Japandi Style Comes to a Custom Picture Framer Near You
-
Form D/A Caxton Macro (USA) LLC
-
Form D/A Caxton Global Investment
-
Form D/A Caxton Advantage (USA)
-
Form D/A Caxton Dynamis (USA)
-
Municipal Finance & Services Corp. Adds Investment Banker Lacarya Scott to Advisory Board
-
Municipal Finance & Services Corp. Adds Investment Banker Lacarya Scott to Advisory Board
-
MORE THAN US AND HENNESSY PRESENT THE B.I.G SUMMIT DURING 2022 NBA ALL-STAR WEEKEND
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A Addex Therapeutics Ltd. Filed by: CAXTON CORP
-
Form SC 13G/A Cardiff Oncology, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A Rezolute, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A CTI BIOPHARMA CORP Filed by: CAXTON CORP
-
Form SC 13G/A Sierra Oncology, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A Savara Inc Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Oct 05 Filed by: CAXTON CORP
-
Form SC 13G Xeris Biopharma Holdings Filed by: CAXTON CORP
-
Blackstone Announces Two New Senior Leadership Hires in BAAM Business
-
Blackstone hires senior executives for its hedge fund unit
-
Dollar retreats as Omicron worries ease; Aussie rises
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Santa Casa da Misericordia de Lisboa Embraces Digital Art and NFTs With the Launch of Artentik
-
Liberated Syndication Announces Bradley Tirpak as CEO
-
Dollar takes a pause ahead of U.S. jobs data
-
Leadgence, a fast-growing platform for dynamic SMB data and analytics for marketing, sales and growth teams, announcing new advisory Board member, Mr. Roger Alexander.
-
Germantown MD Custom Picture Framing/Mounting – Traditional Artwork Promotion
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Speculators' bullish bets on U.S. dollar fall -CFTC, Reuters data
-
LSE's Refinitiv service hit by outage, third since April

